[Therapeutic effect of a new pharmacologic combination in vulvar and vaginal inflammation].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004357:Drug Synergism; D004958:Estradiol / Q000627:therapeutic use*; D005260:Female; D005461:Fluorine / Q000627:therapeutic use*; D011239:Prednisolone; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use*; D014449:Tyrothricin / Q000627:therapeutic use*; D014631:Valerates / Q000627:therapeutic use*; D014848:Vulvovaginitis / Q000188:drug therapy* / Q000209:etiology
D000893:Anti-Inflammatory Agents; D014631:Valerates; D014449:Tyrothricin; D005461:Fluorine; D004958:Estradiol; D011239:Prednisolone; D013421:Sulfamethoxypyridazine
Sull'efficacia terapeutica di una nuova associazione farmacologica nelle flogosi vulvo-vaginali.